Correlation Engine 2.0
Clear Search sequence regions


  • Adrenergic (2)
  • adrenoceptors (5)
  • and disease (1)
  • biosensor (1)
  • cGMP (9)
  • cyclic (3)
  • cyclic gmp (2)
  • heart failure (4)
  • impairs (2)
  • ion (1)
  • PDE2 (1)
  • phosphodiesterases (2)
  • rats (1)
  • receptors (5)
  • signal (3)
  • therapies (1)
  • β3 (5)
  • Sizes of these terms reflect their relevance to your search.

    Cardiomyocyte β3-adrenoceptors (β3-ARs) coupled to soluble guanylyl cyclase (sGC)-dependent production of the second messenger 3',5'-cyclic guanosine monophosphate (cGMP) have been shown to protect from heart failure. However, the exact localization of these receptors to fine membrane structures and subcellular compartmentation of β3-AR/cGMP signals underpinning this protection in health and disease remain elusive. Here, we used a Förster Resonance Energy Transfer (FRET)-based cGMP biosensor combined with scanning ion conductance microscopy (SICM) to show that functional β3-ARs are mostly confined to the T-tubules of healthy rat cardiomyocytes. Heart failure, induced via myocardial infarction, causes a decrease of the cGMP levels generated by these receptors and a change of subcellular cGMP compartmentation. Furthermore, attenuated cGMP signals led to impaired phosphodiesterase two dependent negative cGMP-to-cAMP cross-talk. In conclusion, topographic and functional reorganization of the β3-AR/cGMP signalosome happens in heart failure and should be considered when designing new therapies acting via this receptor. © 2020, Schobesberger et al.

    Citation

    Sophie Schobesberger, Peter T Wright, Claire Poulet, Jose L Sanchez Alonso Mardones, Catherine Mansfield, Andreas Friebe, Sian E Harding, Jean-Luc Balligand, Viacheslav O Nikolaev, Julia Gorelik. β3-Adrenoceptor redistribution impairs NO/cGMP/PDE2 signalling in failing cardiomyocytes. eLife. 2020 Mar 31;9

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 32228862

    View Full Text